PMA device
Automated Impella Controller
Abiomed, Inc. · Temporary Non-Roller Type Right Heart Support Blood Pump (PYX, Class III) · First FDA decision Jan 30, 2020, newest Jan 30, 2020Cardiogenic shockHeart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Automated Impella Controller"
MAUDE reports
4,004
Brand "Automated Impella Controller", since 2015
PubMed studies
6
Mentioning "Automated Impella Controller"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Automated Impella Controller
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Automated Impella ControllerPMA supplement
P170011-S015 · Decided Jan 30, 2020 · 153 days after receipt · Normal 180 Day Track
Device type: Temporary non-roller type right heart support blood pump (PYX) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Counts (Addition of ICD-9-CM Codes V77.1, V81.0, V81.1, and V81.2 to the list of Codes that Do Not Support Medical Necessity)Coding analysisReview closedCAG-00285NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Automated Impella Controller", any status and sponsor, newest update first.
No registered device study names "Automated Impella Controller".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Automated Impella Controller", and for the whole product code for context.
This brand
4,004 reports: 3,744 malfunction, 42 injury, 218 death
Whole product code PYX
2,234 reports: 850 malfunction, 956 injury, 428 death
Newest reports for this brand
- AUTOMATED IMPELLA CONTROLLERMalfunction
ABIOMED EUROPE GMBH - 3007904765
1220648-2026-06833 · Received Apr 15, 2026 · Event dated Apr 6, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Application Program Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- AUTOMATED IMPELLA CONTROLLERMalfunction
1220648-2026-06504 · Received Apr 8, 2026 · Event dated Apr 2, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Device Sensing Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- AUTOMATED IMPELLA CONTROLLERMalfunction
1220648-2026-06428 · Received Apr 6, 2026 · Event dated Mar 28, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Application Program Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Automated Impella Controller, Packaged. Primary user control interface for the Impella Catheter, catheter-based heart pump.Open, Classified
Z-0208-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0209-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Connect Optical AIC, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0210-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
18 more recall records with a free account
Published research
The most relevant PubMed records for "Automated Impella Controller"[tiab]. The summary above synthesizes these.
- A Review of the Impella Devices.
Zein R, Patel C, Mercado-Alamo A, et al. · Interv Cardiol · 2022Review
- Automated Impella Controller overestimates device flow: direct measurement in a mock circulatory loop.
Said CF, Hayward C, Jain P · Eur Heart J Acute Cardiovasc Care · 2026
- Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella.
Basir MB, Bentley D, Truesdell AG, et al. · J Card Fail · 2024Multicenter Study, Observational Study
- Impact of Right Ventricular Dysfunction on Outcomes in Acute Myocardial Infarction and Cardiogenic Shock: Insights from the National Cardiogenic Shock Initiative.
Gorgis S, Gupta K, Lemor A, et al. · J Card Fail · 2024Multicenter Study
- Effective anticoagulation for a percutaneous ventricular assist device using a heparin-based purge solution.
Jennings DL, Nemerovski CW, Kalus JS · Ann Pharmacother · 2013Case Reports
- Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions.
Al-Rashid F, Mahabadi AA, Johannsen L, et al. · Int J Cardiol Heart Vasc · 2020
Other devices of this type
Also filed under product code PYX.
- Impella RP SystemAbiomed, Inc. · PMA 2025
- Impella RP, Impella RP with SmartAssist, and Impella RP Flex with SmartAssistAbiomed, Inc. · PMA 2025
- Impella RP Flex with SmartAssistAbiomed, Inc. · PMA 2022
- Purge CassetteAbiomed, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.